Intelligence Platform

Patents

Browse 405 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7888121

Methods and compositions for targeted cleavage and recombination

Sangamo Biosciences, Inc. · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858657

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7795389

Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combina

The Board of Regents of the University of Texas System · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7795305

CDDO-compounds and combination therapies thereof

granted patent

US 7790158

Methods for epitope-specific and cytokine/anticytokine combination immunotherapies

The Regents of the University of California · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790159

Methods, combinations and kits for treating viral infections using immunoconjugates and an

The Board of Regents of the University of Texas System · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7714109

Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612093

Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imi

United Therapeutics Corporation · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7579333

Therapy using a combination of raloxifene and alendronate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521418

Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacteri

Theravance, Inc. · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7459536

HGF-SF monoclonal antibody combinations

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452861

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial a

Theravance, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7449182

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7445794

Methods for treating human proliferative diseases, with a combination of fatty acid metabo

The Regents of the University of Colorado · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7446124

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7435755

CDDO-compounds and combination therapies thereof

The Board of Regents of the University of Texas System · Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410979

Synergistically effective combinations of dihaloacetamide compounds and interferon or riba

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361332

Treating tumors using implants comprising combinations of allogeneic cells

The Regents of the University of California · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354581

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7331920

Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7271161

Platinum complexes as antitumor agents in combination with biochemical modulation

The Board of Regents of the University of Texas System · Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7186698

Spatial and temporal control of gene expression using a heat shock protein promoter in com

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094408

Immunogenicity using a combination of DNA and vaccinia virus vector vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7087582

Combination for site-specifically transforming cells in vivo comprising a double-balloon c

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted